These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2663140)

  • 41. Tumor characterization using unconventional MR modalities.
    Griffey RH
    Invest Radiol; 1989 Dec; 24(12):985-7. PubMed ID: 2558089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Applications of magnetic resonance in model systems: cancer therapeutics.
    Evelhoch JL; Gillies RJ; Karczmar GS; Koutcher JA; Maxwell RJ; Nalcioglu O; Raghunand N; Ronen SM; Ross BD; Swartz HM
    Neoplasia; 2000; 2(1-2):152-65. PubMed ID: 10933074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo 31P MRS of experimental tumours.
    de Certaines JD; Larsen VA; Podo F; Carpinelli G; Briot O; Henriksen O
    NMR Biomed; 1993; 6(6):345-65. PubMed ID: 8148230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Magnetic resonance spectroscopy of cancer metabolism and response to therapy.
    McIntyre DJ; Madhu B; Lee SH; Griffiths JR
    Radiat Res; 2012 Apr; 177(4):398-435. PubMed ID: 22401303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preliminary observations on the correlation of proliferative phenomena with in vivo 31P NMR spectroscopy after tumor chemotherapy.
    Schiffer LM; Braunschweiger PG; Glickson JD; Evanochko WT; Ng TC
    Ann N Y Acad Sci; 1985; 459():270-7. PubMed ID: 3868326
    [No Abstract]   [Full Text] [Related]  

  • 46. Measurement of tumor pH with in vivo MR spectroscopy.
    Smith SR; Griffiths RD; Martin PA; Edwards RH
    Radiology; 1989 Nov; 173(2):572-4. PubMed ID: 2610757
    [No Abstract]   [Full Text] [Related]  

  • 47. The biochemistry of living tissues: examination by MRS.
    Ross BD
    NMR Biomed; 1992; 5(5):215-9. PubMed ID: 1449959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monitoring therapeutic response of human superficial tumors using phase-encoded spectroscopy.
    Majors AW; Ng TC; Xue M; Meaney TF
    Magn Reson Med; 1989 Dec; 12(3):369-78. PubMed ID: 2628685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nuclear magnetic resonance spectroscopy in the cancer clinic.
    Griffiths JR
    Ann N Y Acad Sci; 1987; 508():176-82. PubMed ID: 3326455
    [No Abstract]   [Full Text] [Related]  

  • 50. Nuclear magnetic resonance: a noninvasive approach to cancer.
    Damadian R
    Hosp Pract; 1977 Jul; 12():63-70. PubMed ID: 873509
    [No Abstract]   [Full Text] [Related]  

  • 51. Tumor assessment and response to therapy studied by magnetic resonance spectroscopy. Proceedings of the 17th L. H. Gray Conference. Canterbury, 13-16 April 1992.
    NMR Biomed; 1992; 5(5):215-328. PubMed ID: 1360249
    [No Abstract]   [Full Text] [Related]  

  • 52. [Present status of experimental chemotherapy of tumors].
    Schmähl D
    Dtsch Med Wochenschr; 1966 Nov; 91(47):2132-5. PubMed ID: 5333844
    [No Abstract]   [Full Text] [Related]  

  • 53. Emerging Role for 7T MRI and Metabolic Imaging for Pancreatic and Liver Cancer.
    Rivera D
    Metabolites; 2022 Apr; 12(5):. PubMed ID: 35629913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Feasibility of
    van Houtum QQ; Mohamed Hoesein FFAA; Verhoeff JJJC; van Rossum PPSN; van Lindert AASR; van der Velden TTA; van der Kemp WWJM; Klomp DDWJ; Arteaga de Castro CCS
    NMR Biomed; 2021 May; 34(5):e4204. PubMed ID: 31736167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low SAR
    van Houtum Q; Welting D; Gosselink WJM; Klomp DWJ; Arteaga de Castro CS; van der Kemp WJM
    NMR Biomed; 2019 Dec; 32(12):e4178. PubMed ID: 31608515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In-vivo
    Valkovič L; Chmelík M; Krššák M
    Anal Biochem; 2017 Jul; 529():193-215. PubMed ID: 28119063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting Phospholipid Metabolism in Cancer.
    Cheng M; Bhujwalla ZM; Glunde K
    Front Oncol; 2016; 6():266. PubMed ID: 28083512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular magnetic resonance imaging in cancer.
    Haris M; Yadav SK; Rizwan A; Singh A; Wang E; Hariharan H; Reddy R; Marincola FM
    J Transl Med; 2015 Sep; 13():313. PubMed ID: 26394751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-field small animal magnetic resonance oncology studies.
    Bokacheva L; Ackerstaff E; LeKaye HC; Zakian K; Koutcher JA
    Phys Med Biol; 2014 Jan; 59(2):R65-R127. PubMed ID: 24374985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of 23Na MRI to monitor chemotherapeutic response in RIF-1 tumors.
    Babsky AM; Hekmatyar SK; Zhang H; Solomon JL; Bansal N
    Neoplasia; 2005 Jul; 7(7):658-66. PubMed ID: 16026645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.